Malaria vaccine efficacy, safety, and community perception in Africa: a scoping review of recent empirical studies

M Chutiyami, P Saravanakumar, UM Bello, D Salihu… - Infection, 2024 - Springer
Aim The review summarizes the recent empirical evidence on the efficacy, safety, and
community perception of malaria vaccines in Africa. Methods Academic Search Complete …

The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for Plasmodium falciparum

E Takashima, H Otsuki, M Morita, D Ito, H Nagaoka… - Biomolecules, 2024 - mdpi.com
Extensive control efforts have significantly reduced malaria cases and deaths over the past
two decades, but in recent years, coupled with the COVID-19 pandemic, success has …

Immune tolerance caused by repeated P. falciparum infection against SE36 malaria vaccine candidate antigen and the resulting limited polymorphism

NMQ Palacpac, KJ Ishii, N Arisue, T Tougan… - Parasitology …, 2023 - Elsevier
The call for second generation malaria vaccines needs not only the identification of novel
candidate antigens or adjuvants but also a better understanding of immune responses and …

Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria

I Nebie, NMQ Palacpac, EC Bougouma, A Diarra… - Vaccines, 2024 - mdpi.com
Information on the dynamics and decline/persistence of antibody titres is important in
vaccine development. A recent vaccine trial in malaria-exposed, healthy African adults and …

[引用][C] Asymptomatic parasitemia and RTS, S vaccine efficacy

N Arisue, NMQ Palacpac - The Lancet Infectious Diseases, 2024 - thelancet.com
Malaria remains one of the most important parasitic diseases worldwide, with an estimated
249 million cases and 608 000 deaths in 2022. 1 In July, 2022, the world's first malaria …